Location History:
- Yongin, KR (2009)
- Gyeonggi-Do, KR (2009)
Company Filing History:
Years Active: 2009
Title: Innovations of Gong-Yeal Lee in Cancer Treatment
Introduction
Gong-Yeal Lee is a notable inventor based in Yongin, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating various types of cancer. With a total of two patents to his name, his work is recognized for its potential impact on cancer therapies.
Latest Patents
Gong-Yeal Lee's latest patents include the N-phenyl-2-pyrimidine-amine derivatives and the process for their preparation. These inventions relate to a novel N-phenyl-2-pyrimidine-amine derivative that demonstrates superior effects on multiple cancers, including lung cancer, gastric cancer, colon cancer, pancreatic cancer, hepatoma, prostatic cancer, breast cancer, chronic or acute leukemia, hematologic malignancy, encephalophyma, bladder cancer, rectal cancer, cervical cancer, and lymphoma in warm-blooded animals. The patents also detail a process for preparing these compounds and a pharmaceutical composition that includes an effective amount of the compound as an active ingredient, along with pharmaceutically acceptable inert carriers.
Career Highlights
Gong-Yeal Lee is associated with Il-Yang Pharm. Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work is characterized by a strong focus on developing effective treatments for serious health conditions, particularly cancer.
Collaborations
Some of his notable coworkers include Dong-Yeon Kim and Dae-Jin Cho, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Gong-Yeal Lee's contributions to cancer treatment through his innovative patents highlight the importance of research in pharmaceuticals. His work at Il-Yang Pharm. Co., Ltd. continues to pave the way for advancements in medical treatments.